Health Care

Innovative ETFs Channel

Specialized Biotech ETF Rallies on MacroGenics Positive Trial Results

By Max ChenFebruary 6, 2019

Core ETF Channel

Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook

By Max ChenJanuary 23, 2019

Leveraged & Inverse Channel

Rising U.S. Health Care Spending a Boon to this Leveraged ETF

By Ben HernandezJanuary 8, 2019

Equity ETFs

Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene

By Max ChenJanuary 3, 2019

Equity ETFs

Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder

By Max ChenDecember 14, 2018

Webcasts

An ETF to Capture Biotech’s Breakthrough of the Century

By Max ChenDecember 4, 2018

Featured

Which Sectors Have Been Naughty and Nice in 2018

By Ben HernandezDecember 4, 2018

Webcasts

The Power of Genome Editing: What Investors Should Know

By Max ChenDecember 3, 2018

Equity ETFs

ETFs to Help Investors Pick and Choose Their Market Exposures

By Max ChenNovember 29, 2018

Equity ETFs

10 Sector ETFs That Could Stand Out in the New Year

By Max ChenNovember 26, 2018

Equity ETFs

Stable, Defensive Sector ETFs for a Wobbly Market

By Max ChenNovember 20, 2018

Equity ETFs

Healthcare ETFs Enjoy Rosy Outlook with Divided Congress

By Max ChenNovember 7, 2018

Leveraged & Inverse Channel

Leveraged Healthcare ETF Gains On Midterm Election Results

By Ben HernandezNovember 7, 2018

Leveraged & Inverse Channel

3 Midterm Election Issues that Could Move Leveraged Healthcare ETF

By Ben HernandezNovember 6, 2018

Robotics & AI

The Robot Will See You Now–AI and Your Health Care

By Ben HernandezOctober 25, 2018

Equity ETFs

ETF Plays for a Divided Midterm Elections

By Max ChenOctober 22, 2018

Equity ETFs

Healthcare ETFs’ Quarterly Checkup Looks Healthy

By Max ChenOctober 16, 2018

Advisor Solutions Channel

Health Care ETFs Retreat on DOJ Approval of Aetna-CVS Merger

By Ben HernandezOctober 10, 2018